Results 31 to 40 of about 433,882 (351)

SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study

open access: yesAnnals of Medicine
Introduction Vaccination hesitancy is an important barrier to vaccination among IBD patients. The development of adverse events is the main concern reported.
Laura N. Rossier   +6 more
doaj   +1 more source

Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome, and immune responses in colitis.

open access: yesNature Materials, 2019
While conventional approaches for inflammatory bowel diseases mainly focus on suppressing hyperactive immune responses, it remains unclear how to address disrupted intestinal barriers, dysbiosis of the gut commensal microbiota and dysregulated mucosal ...
Yonghyun Lee   +5 more
semanticscholar   +1 more source

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Geriatric Inpatients at a German Tertiary University Teaching Hospital: A Retrospective Observational Cohort Study of Clinical Practice

open access: yesAnemia, 2015
Current iron supplementation practice in geriatric patients is erratic and lacks evidence-based recommendations. Despite potential benefits in this population, intravenous iron supplementation is often withheld due to concerns regarding pharmacy expense,
Matthias Bach   +6 more
doaj   +1 more source

Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation

open access: yesMicrobiology spectrum, 2021
The gut microbiota and host immune response interaction influences the progression of intestinal inflammatory disease. As a well-recognized next-generation probiotic, Akkermansia muciniphila has been proved to play a crucial role in the progression of ...
Siwen Qu   +8 more
semanticscholar   +1 more source

An Etiologic Profile of Anemia in 405 Geriatric Patients

open access: yesAnemia, 2014
Background. Anemia is a common condition in the elderly and a significant risk factor for increased morbidity and mortality, reducing not only functional capacity and mobility but also quality of life.
Tabea Geisel   +6 more
doaj   +1 more source

The Establishment of a National Tissue Bank for Inflammatory Bowel Disease Research in Canada

open access: yesCanadian Journal of Gastroenterology, 2003
The Crohn’s and Colitis Foundation of Canada (CCFC) has established a national bank for tissue, serum and blood from patients with inflammatory bowel disease (IBD).
Stephen M Collins   +3 more
doaj   +1 more source

Colitis isquémica. Colitis microscópica

open access: yesMedicine - Programa de Formación Médica Continuada Acreditado, 2016
Resumen Introduccion. La colitis isquemica y la colitis microscopica son entidades de muy diferente naturaleza, manejo y pronostico, pero afectan con mayor frecuencia y de forma similar a mujeres mayores de 60 anos. Patogenia. Manifestaciones clinicas.
S. Parejo   +3 more
openaire   +2 more sources

SlpB Protein Enhances the Probiotic Potential of L. lactis NCDO 2118 in Colitis Mice Model

open access: yesFrontiers in Pharmacology, 2021
Bacteria used in the production of fermented food products have been investigated for their potential role as modulators of inflammation in gastrointestinal tract disorders such as inflammatory bowel diseases (IBD) that cause irreversible changes in the ...
Giovanna A. Belo   +14 more
doaj   +1 more source

Noninfectious Colitides: Collagenous Colitis, Lymphocytic Colitis, Diversion Colitis, and Chemically Induced Colitis [PDF]

open access: yesClinics in Colon and Rectal Surgery, 2007
Approximately 10% of patients with chronic diarrhea carry a diagnosis of microscopic colitis. The endoscopic appearance of both collagenous colitis and lymphocytic colitis may be normal; however, biopsies confirm the diagnosis. Available treatments include antidiarrheals, bismuth salicylate, and budesonide.
openaire   +3 more sources

Insights into PI3K/AKT signaling in B cell development and chronic lymphocytic leukemia

open access: yesFEBS Letters, EarlyView.
This Review explores how the phosphoinositide 3‐kinase and protein kinase B pathway shapes B cell development and drives chronic lymphocytic leukemia, a common blood cancer. It examines how signaling levels affect disease progression, addresses treatment challenges, and introduces novel experimental strategies to improve therapies and patient outcomes.
Maike Buchner
wiley   +1 more source

Home - About - Disclaimer - Privacy